1 mM EDTA, pH 7.4). After

centrifugation through a Spin-X centrifuge tube filter (Corning, U.S.A.), the sterile stock solution was stored at 4 °C for use within one month. A stock of A/PR8 (H1N1) influenza virus propagated on Madin–Darby canine kidney cells (MDCK) was kindly provided by Solvay Biologicals (Weesp, The Netherlands). The virus titer was determined by measuring the tissue culture infectious dose 50 (TCID50). To this end serial twofold dilutions of virus suspension were inoculated on MDCK cells grown in serum-free medium. 1 h later TPCK trypsin (Sigma, Zwijdrecht, Netherlands) was added to a final concentration of 7.5 μg/ml. After 72 h, supernatants were Modulators collected and transferred to a round-bottom 96-well plate followed by the addition of 50 μl 1% guinea pig erythrocytes to each well. The plate

was incubated for 2 h before reading. The titer was determined Selleckchem Enzalutamide as the highest virus dilution at which hemagglutination was visible and the TCID50 was calculated by the method of Reed and Muench [19]. For inactivation, the virus was incubated with freshly prepared 10% β-propiolactone in citrate buffer (125 mM sodium citrate, 150 mM sodium chloride, pH 8.2) at a final concentration of 0.1% β-propiolactone. Inactivation was carried out for 24 h at 4 °C under continuous stirring. After inactivation, the virus was dialyzed against phosphate-buffered saline (PBS) overnight at 4 c. Subunit vaccine was prepared by solubilizing the inactivated virus (0.8 mg virus protein/ml) in PBS

containing Tween 80 (0.3 mg/ml) and hexadecyltrimethylammonium Palbociclib chemical structure bromide (CTAB, 1.5 mg/ml) for 3 h at 4 °C under continuous stirring, and see more removal of the viral nucleocapsid from the preparation by ultracentrifugation for 30 min at 50,000 rpm in a TLA100.3 rotor at 4 c. Detergents were then removed by overnight absorption onto Biobeads SM2 (634 mg/ml, Bio-Rad, Hercules, CA) washed with methanol prior to use. Protein content of the inactivated virus and subunit material was determined by a modified Lowry assay [20]. Hemagglutinin (HA) content was assumed to be one third of the total protein for whole inactivated virus (based on the known protein composition of influenza virus and the molecular weight of the viral proteins) and to be equal to the total protein for subunit material (based on silver-stained SDS polyacrylamide gels run under reducing and non-reducing condition) [21]. Vaccines were mixed at the indicated amounts of subunit and GPI-0100 just before immunization. The protocol for the animal experiment described here was approved by the Ethics Committee on Animal Research of the University of Groningen. Female Balb/c mice (Harlan, The Netherlands) aged 8–10 weeks were grouped (n = 6 per group) and immunized intramuscularly (i.m.) with A/PR/8 subunit vaccine with or without GPI-0100 adjuvant in a two-dose immunization regimen (day 0 and day 20). Control mice were injected with HNE buffer.